Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dementia risk communication. A user manual for Brain Health Services—part 3 of 6
Leonie N.C. Visser, Carolina Minguillón, Gonzalo Sánchez‐Benavides, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Dementia prevention in memory clinics: recommendations from the European task force for brain health services
Giovanni B. Frisoni, Daniele Altomare, Federica Ribaldi, et al.
The Lancet Regional Health - Europe (2023) Vol. 26, pp. 100576-100576
Open Access | Times Cited: 113
Towards a future where Alzheimer’s disease pathology is stopped before the onset of dementia
Wiesje M. van der Flier, Marjolein E. de Vugt, Ellen M.A. Smets, et al.
Nature Aging (2023) Vol. 3, Iss. 5, pp. 494-505
Open Access | Times Cited: 110
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6
Janice M. Ranson, Timothy Rittman, Shabina Hayat, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 75
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6
Alina Solomon, Ruth Stephen, Daniele Altomare, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 60
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6
Daniele Altomare, José Luís Molinuevo, Craig Ritchie, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 45
Impact of sharing Alzheimer's disease biomarkers with individuals without dementia: A systematic review and meta‐analysis of empirical data
Jetske van der Schaar, Leonie N.C. Visser, Johannes C. F. Ket, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 12, pp. 5773-5794
Open Access | Times Cited: 21
Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time
Heleen M.A. Hendriksen, Tanja J. de Rijke, Agnetha D. Fruijtier, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 6556-6565
Open Access | Times Cited: 6
The ATN Framework—Moving Preclinical Alzheimer Disease to Clinical Relevance
Wiesje M. van der Flier, Philip Scheltens
JAMA Neurology (2022) Vol. 79, Iss. 10, pp. 968-968
Closed Access | Times Cited: 27
Genetics of Alzheimer’s Disease in the African American Population
Mark W. Logue, Shoumita Dasgupta, Lindsay A. Farrer
Journal of Clinical Medicine (2023) Vol. 12, Iss. 16, pp. 5189-5189
Open Access | Times Cited: 15
Feasibility and acceptability of remote APOE-genotyping among research volunteers of an online recruitment registry (The Dutch Brain Research Registry)
Lisa Waterink, Sven J. van der Lee, Dionne M. Nijland, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100099-100099
Open Access
The Interdisciplinary Synergy Between Neurology and Psychiatry: Advancing Brain Health
Alice Accorroni, Umberto Nencha, Indrit Bègue
Clinical and Translational Neuroscience (2025) Vol. 9, Iss. 1, pp. 18-18
Open Access
Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities
Giovanni B. Frisoni, Federica Ribaldi, Gilles Allali, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100098-100098
Open Access
A Cross-Sectional Study of Dementia-Related Communication Barriers in Clinical Practice in South India
B Ragasivamalini, V Balambighai, S Nivedhitha, et al.
Cureus (2025)
Open Access
Communication about diagnosis, prognosis, and prevention in the memory clinic: perspectives of European memory clinic professionals
Heleen M.A. Hendriksen, Aniek M. van Gils, Argonde C. van Harten, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Protocols for cognitive enhancement. A user manual for Brain Health Services—part 5 of 6
Andrea Brioschi Guevara, Mélanie Bieler-Aeschlimann, Daniele Altomare, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 6
Richard Milne, Daniele Altomare, Federica Ribaldi, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study
Lisa Waterink, Larissa A Masselink, Sven J. van der Lee, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Brain Health and Cognition in Older Adults: Roadmap and Milestones towards the Implementation of Preventive Strategies
Federico Emanuele Pozzi, Giulia Remoli, Lucio Tremolizzo, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 55-55
Open Access | Times Cited: 2
The expectations and experiences of patients regarding the diagnostic workup at a specialized memory clinic: An interview study
Malin Aspö, Maria Sundell, Myroslava Protsiv, et al.
Health Expectations (2024) Vol. 27, Iss. 2
Open Access | Times Cited: 2
Moving Towards Ethical-Practical Recommendations for Alzheimer’s Disease Prediction: Addressing Interindividual, Interprofessional, and Societal Aspects
Silke Schicktanz, Zümrüt Alpinar-Segawa, Natalie Ulitsa, et al.
Journal of Alzheimer s Disease (2024), pp. 1-19
Closed Access | Times Cited: 2
Disclosure of Genetic Risk Factors for Alzheimer’s Disease to Cognitively Healthy Individuals—From Current Practice towards a Personalised Medicine Scenario
Samantha Galluzzi, Michela Pievani, Orazio Zanetti, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3177-3177
Open Access | Times Cited: 11
Attitudes, Motivations, and Barriers to Pre-Symptomatic Alzheimer’s Disease Screening: Development and Validation of the ‘Perceptions regarding pRE-symptomatic Alzheimer’s Disease Screening’ (PRE-ADS) Questionnaire
Marina Makri, Μάρα Γκιόκα, Despina Μoraitou, et al.
Journal of Alzheimer s Disease (2023) Vol. 95, Iss. 3, pp. 1163-1174
Closed Access | Times Cited: 4
Attitudes of Family Members and Caregivers Regarding Alzheimer’s Disease Pre-Symptomatic Screening
Marina Makri, Akyllina Despoti, Birgit Teichmann, et al.
Journal of Alzheimer s Disease Reports (2024) Vol. 8, Iss. 1, pp. 723-735
Open Access | Times Cited: 1
Contextualising the benefits and risks of anti‐amyloid therapy for patients with Alzheimer disease and their care team
Oneil G. Bhalala, Jane Thompson, Rosie Watson, et al.
The Medical Journal of Australia (2024) Vol. 221, Iss. 2, pp. 78-82
Open Access | Times Cited: 1
Predicting age of onset and progression of disease in late-onset genetic neurodegenerative diseases: An ethics review and research agenda
Max Rensink, Ineke Bolt, Maartje Schermer
European Journal of Human Genetics (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top